{
    "organizations": [],
    "uuid": "3cbd0a97d604e4733e8bec5878c78b6a3b96dec4",
    "author": "",
    "url": "https://www.reuters.com/article/brief-the-medicines-co-reports-q1-gaap-l/brief-the-medicines-co-reports-q1-gaap-loss-per-share-1-14-from-continuing-operations-idUSASC09X9C",
    "ord_in_thread": 0,
    "title": "BRIEF-The Medicines Co Reports Q1 GAAP Loss Per Share $1.14 From Continuing Operations",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 25 (Reuters) - Medicines Co:\n* THE MEDICINES COMPANY REPORTS FIRST-QUARTER 2018 RESULTS\n* Q1 GAAP LOSS PER SHARE $1.14 FROM CONTINUING OPERATIONS * Q1 ADJUSTED NON-GAAP LOSS PER SHARE $0.76 FROM CONTINUING OPERATIONS\n* Q1 EARNINGS PER SHARE VIEW $-0.78 â€” THOMSON REUTERS I/B/E/S\n* QUARTERLY NET REVENUES $7.8 MILLION VERSUS $17.5 MILLION Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-25T14:07:00.000+03:00",
    "crawled": "2018-04-25T14:21:45.017+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "medicine",
        "co",
        "medicine",
        "company",
        "report",
        "result",
        "q1",
        "gaap",
        "loss",
        "per",
        "share",
        "continuing",
        "operation",
        "q1",
        "adjusted",
        "loss",
        "per",
        "share",
        "continuing",
        "operation",
        "q1",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "quarterly",
        "net",
        "revenue",
        "million",
        "versus",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}